VANCOUVER, BC, April 25, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced upcoming event appearances and media coverage for Spring 2023. EVENTS MEDIA VIRTUAL INVESTOR UPDATE ABOUT FILAMENT HEALTH (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) Filament Health is a clinical-stage…


Previous articleBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
Next articlePT407 – The Planet, Psychedelics, and Psyche: Optimism in Ecology